Presented ByDr Timothy Fenske, Medical College of Wisconsin, WI, USA
TrialPhase 3, EA4151 ConferenceASH 2024
TypeNews article
12 December 2024 11:23
Presented ByDr Marie José Kersten, Amsterdam University Medical Center, the Netherlands
TrialPhase 1/2, ATALANTA-1 ConferenceASH 2024
TypeNews article
11 December 2024 10:29
Presented ByDr Daniel DeAngelo, Dana-Farber Cancer Institute, MA, USA
TrialPhase 3 ConferenceASH 2024
TypeNews article
11 December 2024 10:28
Presented ByProf. Luciano Costa, University of Alabama at Birmingham, AL, USA
TrialPhase 1/2, CA057-003 ConferenceASH 2024
TypeNews article
11 December 2024 10:27
Presented ByDr Meletios Dimopoulos, University of Athens, Greece
TrialPhase 3, AQUILA ConferenceASH 2024
TypeNews article
11 December 2024 10:25
Presented ByDr Sattva Neelapu, MD Anderson Cancer Center, TX, USA
TrialPhase 3, ZUMA-5 ConferenceASH 2024
TypeNews article
11 December 2024 10:24
Presented ByProf. Sonja Zweegman, Amsterdam University Medical Centre, the Netherlands
TrialPhase 3, CEPHEUS ConferenceASH 2024
TypeNews article
10 December 2024 09:39
Presented ByDr Rachel Rau, University of Washington, WA, USA
TrialPhase 3, AALL1731 ConferenceASH 2024
TypeNews article
10 December 2024 09:36
Presented ByDr Ibrahim Aldoss, City of Hope, CA, USA
TrialPhase 2, AUGMENT-101 ConferenceASH 2024
TypeNews article
10 December 2024 09:30
Presented ByDr Consuelo Bertossi, University Hospital Ulm, Germany
ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 15:11
Presented ByDr Marc Hoffman, The University of Kansas Cancer Center, KS, USA
TrialPhase 1, CC-220-DLBCL-001 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:27
Presented ByDr Marcel Nijland, University Medical Center Groningen, the Netherlands
TrialPhase 2, HOVON 151 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:27
Presented ByProf. Paolo Ghia, University Vita-Salute San Raffaele, Italy
TrialPhase 3, SEQUOIA ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:27
Presented ByProf. Arnon Kater, University of Amsterdam, the Netherlands
TrialPhase 1/2, EPCORE CLL-1 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:27
Presented ByDr Evgenii Shumilov, University of Münster, Germany
ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:27
Presented ByProf. Michael Wang, University of Texas, TX, USA
TrialPhase 3, ECHO ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:26
Presented ByDr Sarit Assouline, Jewish General Hospital, Canada
TrialPhase 1/2 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:26
Presented ByDr Abhishek Maiti, MD Anderson Cancer Center, TX, USA
TrialPhase 1 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:25
Presented ByProf. Jose Maria Ribera, Josep Carreras Leukaemia Research Institute, Spain
TrialPhase 3, PhALLCON ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:25
Presented ByProf. Uwe Platzbecker, Leipzig University Hospital, Germany
TrialPhase 3, TUD-APOLLO-064 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:25
Presented ByProf. Andreas Hochhaus, Jena University Hospital, Germany
TrialPhase 3, ASC4FIRST ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:25
Presented ByDr Ibrahim Aldoss, City of Hope National Medical Center, CA, USA
TrialPhase 2, AUGMENT-101 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:24
Presented ByDr Wei-Ying Jen, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:20
Presented ByProf. Amer Zeidan, Yale University, CT, USA
ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByDr David Sallman, Moffitt Cancer Center, FL, USA
TrialPhase 3, ENHANCE ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByDr Anne Sophie Kubasch, University of Leipzig, Germany
TrialPhase 2, RELAZA2 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByDr Anna Staffas, University of Gothenburg, Sweden
ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByProf. Thierry Facon, University of Lille, France
TrialPhase 3, IMROZ ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByProf. Pieter Sonneveld, Erasmus University Medical Center, the Netherlands
TrialPhase 3, PERSEUS ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:17
Presented ByProf. Marc Raab, University Hospital Heidelberg, Germany
TrialPhase 3, GMMG-HD7 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:17
Presented ByDr Binod Dhakal, Medical College of Wisconsin, WI, USA
TrialPhase 1 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:17
Presented ByProf. Meletious Dimopoulos, University of Athens, Greece
TrialPhase 3, DREAMM 8 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:16
ExpertSamantha Nier, Acute Leukemia Advocates Network
1 August 2024 14:16
Presented ByDr David Austin, South Tees Hospitals, UK
TrialPhase 3, PROACT ConferenceACC 2024
TypePeer-reviewed article
16 May 2024 14:06
Presented ByDr Francesca Gay, University of Torino, Italy
ConferenceEMN 2024
23 April 2024 11:56
Presented ByDr Rakesh Popat, University College London Hospitals, UK
ConferenceEMN 2024
23 April 2024 11:42
Presented ByDr Alfred Garfall, University of Pennsylvania, PA, USA
ConferenceEMN 2024
23 April 2024 11:39
Presented ByDr Elias K. Mai, University Hospital Heidelberg, Germany
ConferenceEMN 2024
23 April 2024 11:34
Presented ByDr Nizar Bahlis, University of Calgary, Canada
ConferenceEMN2024
23 April 2024 11:27
Presented ByDr Elena Zamagni, Bologna University, Italy
ConferenceEMN 2024
22 April 2024 13:04
Presented ByDr Joannes F. M. Jacobs, Radboud University Medical Center, the Netherlands
ConferenceEMN 2024
22 April 2024 13:02
Presented ByProf. Edward A. Stadtmauer, University of Pennsylvania, PA, USA
ConferenceEMN 2024
22 April 2024 12:59
Presented ByDr Salomon Manier, University of Lille, France
ConferenceEMN 2024
22 April 2024 12:57
Presented ByDr Sara Bringhen, University of Torino, Italy
ConferenceEMN 2024
22 April 2024 12:53
ExpertProf. Monique Minnema, UMC Utrecht, the Netherlands
19 March 2024 14:42
Presented ByProf. Alexander Perl, University of Pennsylvania, PA, USA
TrialPhase 3, QuANTUM-First ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:05
Presented ByDr Jad Othman, Royal North Shore Hospital, Australia
ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByDr Musa Yilmaz, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByDr Ibrahim Aldoss, City of Hope National Medical Center, CA, USA
TrialPhase 2, AUGMENT-101 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByProf. Martin Schrappe, Hong Kong College of Paediatricians, China
TrialPhase 3, AIEOP-BFM ALL 2017 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:02
Presented ByDr Xiaoyuan Gong, Chinese Academy of Medical Sciences, China
TrialPhase 2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:02
Presented ByDr Moritz Fürstenau, University of Cologne, Germany
TrialPhase 2, CLL2-BAAG ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:01
Presented ByProf. Bertram Glass, Helios Klinikum Berlin-Buch, Germany
TrialPhase 2, ASTRAL ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:00
Presented ByDr Paolo Strati, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:00
Presented ByDr Charalambos Andreadis, University of California San Francisco, USA
TrialPhase 3, A051301/BMT-CTN 1201 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Presented ByDr Elizabeth Budde, City of Hope National Medical Center, CA, USA
TrialPhase 1/2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Presented ByProf. Michael Wang, University of Texas, TX, USA
TrialPhase 3, SYMPATICO ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Presented ByProf. Meletios Dimopoulos, University of Athens, Greece
TrialPhase 3, CANDOR ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:58
Presented ByProf. Francesca Gay, University of Torino, Italy
TrialPhase 3, IsKia ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:57
Presented ByProf. Pieter Sonneveld, Erasmus MC, the Netherlands
TrialPhase 3, Perseus ConferenceASH 2023
TypePeer-reviewed article
6 February 2024 16:34
ExpertDr Eliza Hawkes, Olivia Newton-John Cancer Wellness & Research Centre, Australia
TrialPhase 2, WAMM ConferenceASH 2023
4 January 2024 14:30
ExpertProf. Jeff Sharman , The US Oncology Network and Willamette Valley Cancer Institute, Oregon, USA
TrialPhase 3, ELEVATE-TN ConferenceASH 2023
18 December 2023 18:14
ExpertLorna Warwick, Lymphoma Coalition
14 September 2023 09:16
ExpertDr Jennifer Brown, Dana-Farber Cancer Institute & Harvard University, MA, USA
21 August 2023 14:58
Presented ByDr Richard Schlenk, University of Heidelberg, Germany
TrialPhase 3, QuANTUM-First ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 16:54
Presented ByDr Mark Levis, Johns Hopkins Hospital, Maryland, USA
TrialMORPHO ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 16:45
Presented ByDr Maurizio Martelli, University Sapienza Roma, Italy
TrialIELSG37 ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 16:16
Presented ByDr Takahiro Kumode, Kindai University, Japan
TrialPhase 2, MIRAGE ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 16:05
Presented ByDr Michael Clausen, Lillebaelt Hospital, Denmark
TrialPhase 1/2, EPCORETM NHL-2 ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 15:43
Presented ByDr Jeffrey Matous, Colorado Blood Cancer Institute, Colorado, USA
TrialPhase 1, MajesTEC-2 ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 15:21
Presented ByProf. Sebastian Grosicki, Medical University of Silesia, Poland
TrialPhase 1/2, DREAMM 5 ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 15:15
Presented ByDr Hermann Einsele, University of Würzburg, Germany
TrialPhase 3, CARTITUDE-4 ConferenceEHA 2023
TypePeer-reviewed article
2 August 2023 15:08
Presented ByProf. Alex Herrera, City of Hope Medical Center, CA, USA
TrialPhase 3, SWOG S1826 ConferenceASCO 2023
TypePeer-reviewed article
1 August 2023 12:38
Presented ByDr Rachel Giles, Medicom
ConferenceASCO 2023
26 June 2023 03:07
Presented ByDr Emily Liang, University of Washington, WA, USA
TrialPhase 2 ConferenceEBMT 2023
TypePeer-reviewed article
15 June 2023 17:31
Presented ByDr Katy Rezvani, MD Anderson Cancer Center, TX, USA
ConferenceEBMT 2023
TypePeer-reviewed article
15 June 2023 17:20
Presented ByDr Anna Sureda, Catalan Institute of Oncology, Spain
ConferenceEBMT 2023
TypePeer-reviewed article
15 June 2023 17:15
Presented ByDr Paula Rodríguez-Otero, Clinica Universidad de Navarra, Spain
TrialPhase 3, KarMMa-3 ConferenceEBMT 2023
TypePeer-reviewed article
15 June 2023 16:48
Presented ByProf. Salomon Manier, Lille University Hospital, France
TrialPhase 3, CARTITUDE-6 ConferenceEBMT 2023
TypePeer-reviewed article
14 June 2023 20:23
Presented ByDr Hani Hassoun, Memorial Sloan Kettering Cancer Center, NY, USA
TrialPhase 3, DETERMINATION ConferenceEBMT 2023
TypePeer-reviewed article
14 June 2023 20:14
Presented ByProf. Radovan Vrhovac, University Hospital Centre Zagreb, Croatia
TrialPhase 3, QuANTUM-First ConferenceEMBT 2023
TypePeer-reviewed article
14 June 2023 20:07
Presented ByDr Ayman Sayyed, University of Toronto, Canada
ConferenceEBMT 2023
TypePeer-reviewed article
14 June 2023 20:02
Presented ByProf. Olaf Penack, Charité University Hospital of Berlin, Germany
ConferenceEBMT 2023
TypePeer-reviewed article
14 June 2023 19:55
Presented ByDr Gesine Bug, Goethe University Frankfurt, Germany
ConferenceEBMT 2023
TypePeer-reviewed article
14 June 2023 19:48
Presented ByProf. Edmund Waller, Emory University, GA, USA
ConferenceEBMT 2023
TypePeer-reviewed article
14 June 2023 19:42
Presented ByProf. Tomas Neilan, Massachusetts General Hospital, MA, USA
TrialPhase 2, STOP-CA ConferenceACC 2023
TypePeer-reviewed article
7 June 2023 09:58
TrialPhase 2, ELOQUENT-3
17 April 2023 14:28
ExpertDr Sergio Giralt, Memorial Sloan Kettering Cancer Center, USA
TrialPhase 3, KarMMa-3
17 April 2023 12:45
Presented ByProf. Martin Dreyling, University Hospital Munich, Germany
TrialPhase 3, Triangle ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:39
Presented ByProf. Gerald Illerhaus, Klinikum Stuttgart, Germany
TrialPhase 3, MATRix/IELSG43 ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:37
Presented ByProf. Won-Seog Kim, Samsung Medical Center, South Korea
TrialPhase 2, ELM-2 trial ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:30
Presented ByDr Yago Nieto, University of Texas, TX, USA
ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:27
Presented ByDr Kai Rejeski, LMU Munich, Germany
ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:23
Presented ByProf. Ajai Chari, Mount Sinai School of Medicine, NY, USA
TrialPhase 1/2, MonumenTAL-1 ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:19
Presented ByProf. Nizar Bahlis, University of Calgary, Canada
TrialPhase 2, MagnetisMM-3 ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:09
Presented ByProf. Shaji Kumar, Mayo Clinic, MN, USA
TrialPhase 2, ASCENT ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:04